SCHEMBL7474368

SCHEMBL7474368

O=C(O)c1ccccc1Cc1cc2cc(OCc3ccc(C(F)(F)F)cc3)ccc2[nH]1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.52
ALDH1A1 P00352 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C9 P11712 1/20 0.52
HPGD P15428 1/20 0.52
SRD5A2 P31213 1/20 0.52
HSD17B10 Q99714 1/20 0.52
PDGFRB P09619 1/20 0.47
PDGFRA P16234 1/20 0.47
MRGPRX4 Q96LA9 1/20 0.47
MAOB P27338 4/20 0.46
PPARA Q07869 4/20 0.45
MAOA P21397 1/20 0.44
PPARG P37231 2/20 0.43
PPARD Q03181 2/20 0.43
FFAR1 O14842 1/20 0.43
FFAR4 Q5NUL3 1/20 0.43
CFD P00746 1/20 0.43
KDM4C Q9H3R0 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7551194 0.78 PPARG (0.58) KDM4EALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL7474373 0.75 PPARD (0.65) MRGPRX4MAOBPPARAPPARD
SCHEMBL18440586 0.73 SRD5A2 (0.55) SRD5A2MRGPRX4KDM4C
SCHEMBL7554575 0.72 PPARA (0.44) KDM4EALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL15141030 0.72 SRD5A2 (0.68) KDM4EALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL8187385 0.72 MAOA (0.59) KDM4EALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL4424324 0.72 MAOB (0.59) MRGPRX4MAOBPPARAMAOAPPARG
SCHEMBL7814884 0.71 PTGER3 (0.57) KDM4EALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL7814883 0.71 PTGER3 (0.57) KDM4EALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL8158239 0.71 FFAR1 (0.58) MAOBPPARAMAOAPPARGFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1252178-A1 ALPHA-KETOAMIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-10-30 EP claimed
WO-2001040262-A1 ALPHA-KETOAMIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-06-07 WO claimed